United Kingdom· GB-APID-30006311000001108
Cabergoline 1mg tablets
A cabergoline product containing cabergoline, registered in United Kingdom by Mawdsley-Brooks & Company Ltd. The same ATC class is registered in 8 of our 19 countries.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
Where it is registered
Cabergoline is registered in 8 of 19 countries.
Countries holding a registration under ATC N04BC06 (cabergoline), each read from that country’s own register.
- This record: United Kingdom, from NHS dm+d (United Kingdom)
- 4 of them publish a price we can compare per daily dose
Cabergoline · ATC N04BC06
8 / 19 countries
- Belgiumprice
- Denmark
- Finlandprice
- Germany
- Ireland
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of cabergoline costs, country by country.
Normalised to the WHO defined daily dose (3 mg), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Cabergoline · price per daily dose (3 mg)
USD · FX 28 Sept 2026
- FR France$20.42
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Cabergoline
- Manufacturer
- Mawdsley-Brooks & Company Ltd
- Country
- United Kingdom (GB)
- ATC code
- N04BC06
- ATC class
- Cabergoline
- Defined daily dose
- 3 mg, O
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
65 interactions on record for cabergoline.
Graded by severity as the source publishes them — 3 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Cabergoline · interactions on record
65 records
- 3 severe
- 17 moderate
- 45 info
Most severe, free to view
- LorcaserinA08AA11severe
- ErythromycinJ01FA01severe
- ClarithromycinJ01FA09severe
- MetoclopramideA03FA01moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Cabergoline in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SwedenCabergoline Hexal 1 mg TablettHexal A/S
- SpainCABERGOLINA TEVA 1 mg COMPRIMIDOS EFGTeva Pharma S.L.U.
- FinlandCabaserPfizer Oy
- IrelandCabaser 1 mg TabletPfizer Healthcare Ireland Unlimited Company
- SwitzerlandCabaser 1 mg, TablettenPfizer AG
- PolandDostinexPretium Farm Sp. z o.o.
- United StatesCabergolineA-S Medication Solutions
- GermanyCabaserilPfizer Pharma Gmbh
Authorised across Europe · EMA
The same active substance is authorised in 25 EEA countries. Names it is sold under:
- Austria · Cabaseril, Dostinex
- Belgium · Cabergoline Teva, Dostinex
- Bulgaria · Достинекс
- Cyprus · Dostinex
- Czechia · Dostinex
- Germany · Cabaseril, Cabergoletten
- Denmark · Cabenex, Cabergolin Teva
- Spain · Cabergolina Teva, Dostinex
- Finland · Cabaser, Dostinex
- France · Cabergoline Arrow, Cabergoline Biogaran
- Greece · Dostinex
- Croatia · Dostinex
- Ireland · Cabaser, Cabergoline Renata Pharmaceuticals (Ireland)
- Iceland · Dostinex
- Italy · Cabaser, Cabergolina Aurobindo
- Luxembourg · Cabergoline Teva, Dostinex
- Latvia · Dostinex
- Malta · Cabergoline Aurobindo, Cabergoline Doc
- Netherlands · Cabergoline Aurobindo, Cabergoline Pch
- Norway · Cabergoline Renata Pharmaceuticals (Ireland), Dostinex
- Poland · Dostinex
- Portugal · Cabergolina Generis, Cabergoline 0.5 Mg Tablets
- Romania · Dostinex
- Sweden · Cabenex, Cabergoline Ratiopharm
- Slovakia · Cabest
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f1a3c046-a876-4fda-bdac-22613e67d9a6 GET /v1/drugs/f1a3c046-a876-4fda-bdac-22613e67d9a6?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "30006311000001108",
"desc": "Cabergoline 1mg tablets (Mawdsley-Brooks & Company Ltd)",
"form": "Oral tablet",
"vpid": "41872211000001100",
"source": "dmd",
"vtm_id": "774961008",
"strength": "1 mg",
"substance": "Cabergoline",
"ingredient": "Cabergoline",
"supplier_code": "15125811000001100"
}See everything about cabergoline.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.